{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T10:43:31Z","timestamp":1792579411240,"version":"4.5.0"},"reference-count":89,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:00:00Z","timestamp":1783036800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:00:00Z","timestamp":1783036800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neural Transm"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s00702-026-03207-y","type":"journal-article","created":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T12:14:08Z","timestamp":1783080848000},"page":"2069-2082","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Dopamine supersensitivity psychosis: a critical evaluation of diagnostic validators"],"prefix":"10.1007","volume":"133","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-6997-1158","authenticated-orcid":false,"given":"Liam","family":"Koro\u0161ec Hudnik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivo","family":"Kosma\u010din","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-8581-2840","authenticated-orcid":false,"given":"Milica","family":"Pjevac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vita","family":"Dol\u017ean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5303-2044","authenticated-orcid":false,"given":"Jurij","family":"Bon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,3]]},"reference":[{"key":"3207_CR1","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/s0920-9964(02)00338-9","volume":"63","author":"JA Apud","year":"2003","unstructured":"Apud JA, Egan MF, Wyatt RJ (2003) Neuroleptic withdrawal in treatment-resistant patients with schizophrenia: tardive dyskinesia is not associated with supersensitive psychosis. Schizophr Res 63:151\u2013160. https:\/\/doi.org\/10.1016\/s0920-9964(02)00338-9","journal-title":"Schizophr Res"},{"key":"3207_CR2","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/0014-2999(73)90028-9","volume":"22","author":"H Asper","year":"1973","unstructured":"Asper H, Baggiolini M, Burki HR et al (1973) Tolerance phenomena with neuroleptics catalepsy, apomorphine stereotypies and striatal dopamine metabolism in the rat after single and repeated administration of loxapine and haloperidol. Eur J Pharmacol 22:287\u2013294. https:\/\/doi.org\/10.1016\/0014-2999(73)90028-9","journal-title":"Eur J Pharmacol"},{"key":"3207_CR3","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1038\/nn.2862","volume":"14","author":"EP Bello","year":"2011","unstructured":"Bello EP, Mateo Y, Gelman DM et al (2011) Cocaine supersensitivity and enhanced motivation for reward in mice lacking dopamine D2 autoreceptors. Nat Neurosci 14:1033\u20131038. https:\/\/doi.org\/10.1038\/nn.2862","journal-title":"Nat Neurosci"},{"key":"3207_CR4","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/0306-4522(89)90179-6","volume":"28","author":"M Camps","year":"1989","unstructured":"Camps M, Cort\u00e9s R, Gueye B et al (1989) Dopamine receptors in human brain: autoradiographic distribution of D2 sites. Neuroscience 28:275\u2013290. https:\/\/doi.org\/10.1016\/0306-4522(89)90179-6","journal-title":"Neuroscience"},{"key":"3207_CR5","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/0920-9964(91)90050-2","volume":"5","author":"G Chouinard","year":"1991","unstructured":"Chouinard G (1991) Severe cases of neuroleptic-induced supersensitivity psychosis. Schizophr Res 5:21\u201333. https:\/\/doi.org\/10.1016\/0920-9964(91)90050-2","journal-title":"Schizophr Res"},{"key":"3207_CR6","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1176\/ajp.137.1.16","volume":"137","author":"G Chouinard","year":"1980","unstructured":"Chouinard G, Jones BD (1980) Neuroleptic-induced supersensitivity psychosis: clinical and pharmacologic characteristics. Am J Psychiatry 137:16\u201321. https:\/\/doi.org\/10.1176\/ajp.137.1.16","journal-title":"Am J Psychiatry"},{"key":"3207_CR7","first-page":"337","volume":"26","author":"G Chouinard","year":"1990","unstructured":"Chouinard G, Sultan S (1990) Treatment of supersensitivity psychosis with antiepileptic drugs: report of a series of 43 cases. Psychopharmacol Bull 26:337\u2013341","journal-title":"Psychopharmacol Bull"},{"key":"3207_CR8","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1176\/ajp.135.11.1409","volume":"135","author":"G Chouinard","year":"1978","unstructured":"Chouinard G et al (1978) Neuroleptic-induced supersensitivity psychosis. Am J Psychiatry 135:1409\u20131410. https:\/\/doi.org\/10.1176\/ajp.135.11.1409","journal-title":"Am J Psychiatry"},{"key":"3207_CR9","first-page":"891","volume":"22","author":"G Chouinard","year":"1986","unstructured":"Chouinard G, Annable L, Ross-Chouinard A (1986) Supersensitivity psychosis and tardive dyskinesia: a survey in schizophrenic outpatients. Psychopharmacol Bull 22:891\u2013896","journal-title":"Psychopharmacol Bull"},{"key":"3207_CR10","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/0278-5846(94)90116-3","volume":"18","author":"G Chouinard","year":"1994","unstructured":"Chouinard G, Vainer JL, B\u00e9langer M-C et al (1994) Risperidone and clozapine in the treatment of drug-resistant schizophrenia and neuroleptic-induced supersensitivity psychosis. Prog Neuropsychopharmacol Biol Psychiatry 18:1129\u20131141. https:\/\/doi.org\/10.1016\/0278-5846(94)90116-3","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"3207_CR11","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1159\/000477313","volume":"86","author":"G Chouinard","year":"2017","unstructured":"Chouinard G, Samaha A-N, Chouinard V-A et al (2017) Antipsychotic-Induced Dopamine Supersensitivity Psychosis: Pharmacology, Criteria, and Therapy. Psychother Psychosom 86:189\u2013219. https:\/\/doi.org\/10.1159\/000477313","journal-title":"Psychother Psychosom"},{"key":"3207_CR12","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1159\/000506868","volume":"89","author":"F Cosci","year":"2020","unstructured":"Cosci F, Chouinard G (2020) Acute and Persistent Withdrawal Syndromes Following Discontinuation of Psychotropic Medications. Psychother Psychosom 89:283\u2013306. https:\/\/doi.org\/10.1159\/000506868","journal-title":"Psychother Psychosom"},{"key":"3207_CR13","unstructured":"Cusick E, Gupta V (2024) Pimavanserin. In: StatPearls. StatPearls Publishing, Treasure Island (FL)"},{"key":"3207_CR14","first-page":"699","volume":"14","author":"KL Davis","year":"1979","unstructured":"Davis KL, Rosenberg GS (1979) Is there a limbic system equivalent of tardive dyskinesia? Biol Psychiatry 14:699\u2013703","journal-title":"Biol Psychiatry"},{"key":"3207_CR15","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/0304-3940(88)90758-6","volume":"91","author":"J De Keyser","year":"1988","unstructured":"De Keyser J, Claeys A, De Backer JP et al (1988) Autoradiographic localization of D1 and D2 dopamine receptors in the human brain. Neurosci Lett 91:142\u2013147. https:\/\/doi.org\/10.1016\/0304-3940(88)90758-6","journal-title":"Neurosci Lett"},{"key":"3207_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-020-02895-4","volume":"20","author":"JA Dennis","year":"2020","unstructured":"Dennis JA, Gittner LS, Payne JD, Nugent K (2020) Characteristics of U.S. adults taking prescription antipsychotic medications, National Health and Nutrition Examination Survey 2013\u20132018. BMC Psychiatry 20:483. https:\/\/doi.org\/10.1186\/s12888-020-02895-4","journal-title":"BMC Psychiatry"},{"key":"3207_CR17","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1007\/s12031-013-0158-6","volume":"52","author":"J Deslauriers","year":"2014","unstructured":"Deslauriers J, Desmarais C, Sarret P, Grignon S (2014) Implication of the ERK\/MAPK Pathway in Antipsychotics-induced Dopamine D2 Receptor Upregulation and in the Preventive Effects of (\u00b1)-\u03b1-lipoic acid in SH-SY5Y Neuroblastoma Cells. J Mol Neurosci 52:378\u2013383. https:\/\/doi.org\/10.1007\/s12031-013-0158-6","journal-title":"J Mol Neurosci"},{"key":"3207_CR18","first-page":"144","volume":"35","author":"C Egan","year":"2000","unstructured":"Egan C, Grinde E, Dupre A et al (2000) Agonist high and low affinity state ratios predict drug intrinsic activity and a revised ternary complex mechanism at serotonin 5-HT(2A) and 5-HT(2C) receptors. Synap N Y N 35:144\u2013150","journal-title":"Synap N Y N"},{"key":"3207_CR19","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.17m11874","author":"R Emsley","year":"2018","unstructured":"Emsley R, Nuamah I, Gopal S et al (2018) Relapse after antipsychotic discontinuation in schizophrenia as a withdrawal phenomenon vs illness recurrence: a post hoc analysis of a randomized placebo-controlled study. J Clin Psychiatry. https:\/\/doi.org\/10.4088\/JCP.17m11874","journal-title":"J Clin Psychiatry"},{"key":"3207_CR20","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1177\/0269881109359097","volume":"25","author":"P Fallon","year":"2011","unstructured":"Fallon P, Dursun SM (2011) A naturalistic controlled study of relapsing schizophrenic patients with tardive dyskinesia and supersensitivity psychosis. J Psychopharmacol (Oxf) 25:755\u2013762. https:\/\/doi.org\/10.1177\/0269881109359097","journal-title":"J Psychopharmacol (Oxf)"},{"key":"3207_CR21","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1177\/2045125311431105","volume":"2","author":"P Fallon","year":"2012","unstructured":"Fallon P, Dursun S, Deakin B (2012) Drug-induced supersensitivity psychosis revisited: characteristics of relapse in treatment-compliant patients. Ther Adv Psychopharmacol 2:13\u201322. https:\/\/doi.org\/10.1177\/2045125311431105","journal-title":"Ther Adv Psychopharmacol"},{"key":"3207_CR22","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.neuroscience.2014.01.025","volume":"282","author":"CP Ford","year":"2014","unstructured":"Ford CP (2014) The Role of D2-Autoreceptors in Regulating Dopamine Neuron Activity and Transmission. Neuroscience 282:13\u201322. https:\/\/doi.org\/10.1016\/j.neuroscience.2014.01.025","journal-title":"Neuroscience"},{"key":"3207_CR23","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1016\/0024-3205(74)90078-2","volume":"14","author":"G Gianutsos","year":"1974","unstructured":"Gianutsos G, Drawbaugh RB, Hynes MD, Lal H (1974) Behavioral evidence for dopaminergic supersensitivity after chronic haloperidol. Life Sci 14:887\u2013898. https:\/\/doi.org\/10.1016\/0024-3205(74)90078-2","journal-title":"Life Sci"},{"key":"3207_CR24","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1176\/ajp.137.8.992","volume":"137","author":"CG Goetz","year":"1980","unstructured":"Goetz CG (1980) Defining drug-induced supersensitivity. Am J Psychiatry 137:992\u2013993. https:\/\/doi.org\/10.1176\/ajp.137.8.992","journal-title":"Am J Psychiatry"},{"key":"3207_CR25","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/0024-3205(83)90134-0","volume":"33","author":"R Halperin","year":"1983","unstructured":"Halperin R, Guerin JJ, Davis KL (1983) Chronic administration of three neuroleptics: effects of behavioral supersensitivity mediated by two different brain regions in the rat. Life Sci 33:585\u2013592. https:\/\/doi.org\/10.1016\/0024-3205(83)90134-0","journal-title":"Life Sci"},{"key":"3207_CR26","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.tins.2023.11.006","volume":"47","author":"R Jordan","year":"2024","unstructured":"Jordan R (2024) The locus coeruleus as a global model failure system. Trends Neurosci 47:92\u2013105. https:\/\/doi.org\/10.1016\/j.tins.2023.11.006","journal-title":"Trends Neurosci"},{"key":"3207_CR27","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1097\/YIC.0000000000000257","volume":"34","author":"N Kanahara","year":"2019","unstructured":"Kanahara N, Yoshimura K, Nakamura M et al (2019) Metabolism of risperidone by CYP2D6 and the presence of drug-induced dopamine supersensitivity psychosis in patients with schizophrenia. Int Clin Psychopharmacol 34:124\u2013130. https:\/\/doi.org\/10.1097\/YIC.0000000000000257","journal-title":"Int Clin Psychopharmacol"},{"key":"3207_CR28","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1097\/YIC.0000000000000322","volume":"35","author":"N Kanahara","year":"2020","unstructured":"Kanahara N, Takase M, Sasaki T et al (2020) The effectiveness of very slow switching to aripiprazole in schizophrenia patients with dopamine supersensitivity psychosis: a case series from an open study. Int Clin Psychopharmacol 35:338\u2013344. https:\/\/doi.org\/10.1097\/YIC.0000000000000322","journal-title":"Int Clin Psychopharmacol"},{"key":"3207_CR29","doi-asserted-by":"publisher","first-page":"2214","DOI":"10.2174\/1570159X19666210125152815","volume":"19","author":"N Kanahara","year":"2021","unstructured":"Kanahara N, Kimura H, Oda Y et al (2021) Recent discussions on dopamine supersensitivity psychosis: eight points to consider when diagnosing treatment-resistant schizophrenia. Curr Neuropharmacol 19:2214\u20132226. https:\/\/doi.org\/10.2174\/1570159X19666210125152815","journal-title":"Curr Neuropharmacol"},{"key":"3207_CR30","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.schres.2014.02.022","volume":"155","author":"H Kimura","year":"2014","unstructured":"Kimura H, Kanahara N, Komatsu N et al (2014) A prospective comparative study of risperidone long-acting injectable for treatment-resistant schizophrenia with dopamine supersensitivity psychosis. Schizophr Res 155:52\u201358. https:\/\/doi.org\/10.1016\/j.schres.2014.02.022","journal-title":"Schizophr Res"},{"key":"3207_CR31","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/BF01245320","volume":"33","author":"HL Klawans","year":"1972","unstructured":"Klawans HL, Rubovits R (1972) An experimental model of tardive dyskinesia. J Neural Transm 33:235\u2013246. https:\/\/doi.org\/10.1007\/BF01245320","journal-title":"J Neural Transm"},{"key":"3207_CR32","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1097\/JCP.0000000000001564","volume":"42","author":"M Kogure","year":"2022","unstructured":"Kogure M, Kanahara N, Kimura M et al (2022) Long-term treatment with long-acting injectable antipsychotic in schizophrenia patients with and without dopamine supersensitivity psychosis: a 6-year retrospective comparative study. J Clin Psychopharmacol 42:357\u2013364. https:\/\/doi.org\/10.1097\/JCP.0000000000001564","journal-title":"J Clin Psychopharmacol"},{"key":"3207_CR33","doi-asserted-by":"publisher","first-page":"892","DOI":"10.4088\/JCP.v63n1007","volume":"63","author":"JP Lacro","year":"2002","unstructured":"Lacro JP, Dunn LB, Dolder CR et al (2002) Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature. J Clin Psychiatry 63:892\u2013909. https:\/\/doi.org\/10.4088\/JCP.v63n1007","journal-title":"J Clin Psychiatry"},{"key":"3207_CR34","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.neuroscience.2017.07.068","volume":"361","author":"C L\u00e9vesque","year":"2017","unstructured":"L\u00e9vesque C, Hernandez G, Mahmoudi S et al (2017) Deficient striatal adaptation in aminergic and glutamatergic neurotransmission is associated with tardive dyskinesia in non-human primates exposed to antipsychotic drugs. Neuroscience 361:43\u201357. https:\/\/doi.org\/10.1016\/j.neuroscience.2017.07.068","journal-title":"Neuroscience"},{"key":"3207_CR35","first-page":"87","volume":"46","author":"PM Llorca","year":"2001","unstructured":"Llorca PM, Vaiva G, Lancon C (2001) Supersensitivity psychosis in patients with schizophrenia after sudden olanzapine withdrawal. Can J Psychiatry Rev Can Psychiatr 46:87\u201388","journal-title":"Can J Psychiatry Rev Can Psychiatr"},{"key":"3207_CR36","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1345\/aph.1A440","volume":"36","author":"M-L Lu","year":"2002","unstructured":"Lu M-L, Pan J-J, Teng H-W et al (2002) Metoclopramide-induced supersensitivity psychosis. Ann Pharmacother 36:1387\u20131390. https:\/\/doi.org\/10.1345\/aph.1A440","journal-title":"Ann Pharmacother"},{"key":"3207_CR37","doi-asserted-by":"publisher","first-page":"204512532110643","DOI":"10.1177\/20451253211064396","volume":"12","author":"C-H Ma","year":"2022","unstructured":"Ma C-H, Chan H-Y, Hsieh MH et al (2022) Identifying dopamine supersensitivity through a randomized controlled study of switching to aripiprazole from other antipsychotic agents in patients with schizophrenia. Ther Adv Psychopharmacol 12:20451253211064396. https:\/\/doi.org\/10.1177\/20451253211064396","journal-title":"Ther Adv Psychopharmacol"},{"key":"3207_CR38","doi-asserted-by":"publisher","DOI":"10.1097\/YIC.0000000000000442","author":"Y Masumo","year":"2022","unstructured":"Masumo Y, Kanahara N, Kogure M et al (2022) Dopamine supersensitivity psychosis and delay of clozapine treatment in patients with treatment-resistant schizophrenia. Int Clin Psychopharmacol. https:\/\/doi.org\/10.1097\/YIC.0000000000000442","journal-title":"Int Clin Psychopharmacol"},{"key":"3207_CR39","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1192\/bjp.bp.108.050088","volume":"193","author":"DD Miller","year":"2008","unstructured":"Miller DD, Caroff SN, Davis SM et al (2008) Extrapyramidal side-effects of antipsychotics in a randomised trial. Br J Psychiatry 193:279\u2013288. https:\/\/doi.org\/10.1192\/bjp.bp.108.050088","journal-title":"Br J Psychiatry"},{"key":"3207_CR40","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/j.1600-0447.2006.00787.x","volume":"114","author":"J Moncrieff","year":"2006","unstructured":"Moncrieff J (2006) Does antipsychotic withdrawal provoke psychosis? Review of the literature on rapid onset psychosis (supersensitivity psychosis) and withdrawal-related relapse. Acta Psychiatr Scand 114:3\u201313. https:\/\/doi.org\/10.1111\/j.1600-0447.2006.00787.x","journal-title":"Acta Psychiatr Scand"},{"key":"3207_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0014-2999(82)90595-7","volume":"81","author":"N Montanaro","year":"1982","unstructured":"Montanaro N, Dall\u2019Olio R, Gandolfi O, Vaccheri A (1982) Differential enhancement of behavioral sensitivity to apomorphine following chronic treatment of rats with (\u2212)-sulpiride and haloperidol. Eur J Pharmacol 81:1\u20139. https:\/\/doi.org\/10.1016\/0014-2999(82)90595-7","journal-title":"Eur J Pharmacol"},{"key":"3207_CR42","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.11124\/JBISRIR-D-19-00099","volume":"18","author":"Z Munn","year":"2020","unstructured":"Munn Z, Barker TH, Moola S et al (2020) Methodological quality of case series studies: an introduction to the JBI critical appraisal tool. JBI Database Syst Rev Implement Rep 18:2127\u20132133. https:\/\/doi.org\/10.11124\/JBISRIR-D-19-00099","journal-title":"JBI Database Syst Rev Implement Rep"},{"key":"3207_CR43","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1136\/bmjebm-2017-110853","volume":"23","author":"MH Murad","year":"2018","unstructured":"Murad MH, Sultan S, Haffar S, Bazerbachi F (2018) Methodological quality and synthesis of case series and case reports. BMJ Evid-Based Med 23:60\u201363. https:\/\/doi.org\/10.1136\/bmjebm-2017-110853","journal-title":"BMJ Evid-Based Med"},{"key":"3207_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajp.2021.102845","volume":"65","author":"T Murata","year":"2021","unstructured":"Murata T, Negishi T, Yuki K et al (2021) Post-clozapine in a clinical setting: A retrospective case note review in Kumamoto, Japan (2009\u20132019). Asian J Psychiatry 65:102845. https:\/\/doi.org\/10.1016\/j.ajp.2021.102845","journal-title":"Asian J Psychiatry"},{"key":"3207_CR45","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1177\/0269881117728428","volume":"31","author":"Y Nakata","year":"2017","unstructured":"Nakata Y, Kanahara N, Iyo M (2017) Dopamine supersensitivity psychosis in schizophrenia: concepts and implications in clinical practice. J Psychopharmacol (Oxf) 31:1511\u20131518. https:\/\/doi.org\/10.1177\/0269881117728428","journal-title":"J Psychopharmacol (Oxf)"},{"key":"3207_CR46","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1097\/YIC.0000000000000160","volume":"32","author":"Y Nakata","year":"2017","unstructured":"Nakata Y, Kanahara N, Kimura H et al (2017b) Efficacy of clozapine on dopamine supersensitivity psychosis in schizophrenia. Int Clin Psychopharmacol 32:169\u2013173. https:\/\/doi.org\/10.1097\/YIC.0000000000000160","journal-title":"Int Clin Psychopharmacol"},{"key":"3207_CR47","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/S0014-2999(00)00136-9","volume":"394","author":"FJ Nasif","year":"2000","unstructured":"Nasif FJ, Cuadra GR, Ramirez OA (2000) Effects of chronic risperidone on central noradrenergic transmission. Eur J Pharmacol 394:67\u201373. https:\/\/doi.org\/10.1016\/S0014-2999(00)00136-9","journal-title":"Eur J Pharmacol"},{"key":"3207_CR48","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1017\/S1461145705005080","volume":"8","author":"LK Nilsson","year":"2005","unstructured":"Nilsson LK, Schwieler L, Engberg G et al (2005) Activation of noradrenergic locus coeruleus neurons by clozapine and haloperidol: involvement of glutamatergic mechanisms. Int J Neuropsychopharmacol 8:329\u2013339. https:\/\/doi.org\/10.1017\/S1461145705005080","journal-title":"Int J Neuropsychopharmacol"},{"key":"3207_CR49","doi-asserted-by":"publisher","first-page":"30144","DOI":"10.3390\/ijms161226228","volume":"16","author":"Y Oda","year":"2015","unstructured":"Oda Y, Kanahara N, Iyo M (2015a) Alterations of dopamine D2 receptors and related receptor-interacting proteins in schizophrenia: the pivotal position of dopamine supersensitivity psychosis in treatment-resistant schizophrenia. Int J Mol Sci 16:30144\u201330163. https:\/\/doi.org\/10.3390\/ijms161226228","journal-title":"Int J Mol Sci"},{"key":"3207_CR50","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.2147\/NDT.S86042","volume":"11","author":"Y Oda","year":"2015","unstructured":"Oda Y, Kanahara N, Kimura H et al (2015b) Genetic association between G protein-coupled receptor kinase 6\/\u03b2-arrestin 2 and dopamine supersensitivity psychosis in schizophrenia. Neuropsychiatr Dis Treat 11:1845\u20131851. https:\/\/doi.org\/10.2147\/NDT.S86042","journal-title":"Neuropsychiatr Dis Treat"},{"key":"3207_CR51","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0207133","volume":"13","author":"K Oishi","year":"2018","unstructured":"Oishi K, Kanahara N, Takase M et al (2018) Vulnerable combinations of functional dopaminergic polymorphisms to late-onset treatment resistant schizophrenia. PLoS ONE 13:e0207133. https:\/\/doi.org\/10.1371\/journal.pone.0207133","journal-title":"PLoS ONE"},{"key":"3207_CR52","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. https:\/\/doi.org\/10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"3207_CR53","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1192\/bjp.bp.111.101485","volume":"200","author":"MJ Peluso","year":"2012","unstructured":"Peluso MJ, Lewis SW, Barnes TRE, Jones PB (2012) Extrapyramidal motor side-effects of first- and second-generation antipsychotic drugs. Br J Psychiatry 200:387\u2013392. https:\/\/doi.org\/10.1192\/bjp.bp.111.101485","journal-title":"Br J Psychiatry"},{"key":"3207_CR54","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1007\/BF00432771","volume":"77","author":"GV Rebec","year":"1982","unstructured":"Rebec GV, Peirson EE, McPherson FA, Brugge K (1982) Differential sensitivity to amphetamine following long-term treatment with clozapine or haloperidol. Psychopharmacology (Berl) 77:360\u2013366. https:\/\/doi.org\/10.1007\/BF00432771","journal-title":"Psychopharmacology (Berl)"},{"key":"3207_CR55","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1007\/s00702-021-02453-6","volume":"129","author":"GP Reynolds","year":"2022","unstructured":"Reynolds GP (2022) The neurochemical pathology of schizophrenia: post-mortem studies from dopamine to parvalbumin. J Neural Transm 129:643\u2013647. https:\/\/doi.org\/10.1007\/s00702-021-02453-6","journal-title":"J Neural Transm"},{"key":"3207_CR56","doi-asserted-by":"publisher","DOI":"10.3389\/fncir.2021.735625","volume":"15","author":"LM Reynolds","year":"2021","unstructured":"Reynolds LM, Flores C (2021) Mesocorticolimbic dopamine pathways across adolescence: diversity in development. Front Neural Circuits 15:735625. https:\/\/doi.org\/10.3389\/fncir.2021.735625","journal-title":"Front Neural Circuits"},{"key":"3207_CR57","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1176\/ajp.126.7.983","volume":"126","author":"E Robins","year":"1970","unstructured":"Robins E, Guze SB (1970) Establishment of diagnostic validity in psychiatric illness: its application to schizophrenia. Am J Psychiatry 126:983\u2013987. https:\/\/doi.org\/10.1176\/ajp.126.7.983","journal-title":"Am J Psychiatry"},{"key":"3207_CR58","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1Q214","volume":"45","author":"J Roy-Desruisseaux","year":"2011","unstructured":"Roy-Desruisseaux J, Landry J, Bocti C et al (2011) Domperidone-induced tardive dyskinesia and withdrawal psychosis in an elderly woman with dementia. Ann Pharmacother 45:e51. https:\/\/doi.org\/10.1345\/aph.1Q214","journal-title":"Ann Pharmacother"},{"key":"3207_CR59","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/S2215-0366(20)30264-9","volume":"7","author":"JM Rubio","year":"2020","unstructured":"Rubio JM, Schoretsanitis G, John M et al (2020) Psychosis relapse during treatment with long-acting injectable antipsychotics in individuals with schizophrenia-spectrum disorders: an individual participant data meta-analysis. Lancet Psychiatry 7:749\u2013761. https:\/\/doi.org\/10.1016\/S2215-0366(20)30264-9","journal-title":"Lancet Psychiatry"},{"key":"3207_CR60","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1097\/YIC.0000000000000391","volume":"37","author":"G Russell","year":"2022","unstructured":"Russell G, Reinfeld S, Kam O et al (2022) Case series on aripiprazole and dopamine supersensitivity psychosis. Int Clin Psychopharmacol 37:122\u2013128. https:\/\/doi.org\/10.1097\/YIC.0000000000000391","journal-title":"Int Clin Psychopharmacol"},{"key":"3207_CR61","doi-asserted-by":"publisher","first-page":"2979","DOI":"10.1523\/JNEUROSCI.5416-06.2007","volume":"27","author":"A-N Samaha","year":"2007","unstructured":"Samaha A-N, Seeman P, Stewart J et al (2007) \u201cBreakthrough\u201d Dopamine Supersensitivity during Ongoing Antipsychotic Treatment Leads to Treatment Failure over Time. J Neurosci 27:2979\u20132986. https:\/\/doi.org\/10.1523\/JNEUROSCI.5416-06.2007","journal-title":"J Neurosci"},{"key":"3207_CR62","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1111\/j.1755-5949.2010.00162.x","volume":"17","author":"P Seeman","year":"2011","unstructured":"Seeman P (2011) All roads to schizophrenia lead to dopamine supersensitivity and elevated dopamine D2(high) receptors. CNS Neurosci Ther 17:118\u2013132. https:\/\/doi.org\/10.1111\/j.1755-5949.2010.00162.x","journal-title":"CNS Neurosci Ther"},{"key":"3207_CR63","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1126\/science.6147018","volume":"225","author":"P Seeman","year":"1984","unstructured":"Seeman P, Ulpian C, Bergeron C et al (1984) Bimodal Distribution of Dopamine Receptor Densities in Brains of Schizophrenics. Science 225:728\u2013731. https:\/\/doi.org\/10.1126\/science.6147018","journal-title":"Science"},{"key":"3207_CR64","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1002\/syn.20303","volume":"60","author":"P Seeman","year":"2006","unstructured":"Seeman P, Schwarz J, Chen J-F et al (2006) Psychosis pathways converge via D2High dopamine receptors. Synapse 60:319\u2013346. https:\/\/doi.org\/10.1002\/syn.20303","journal-title":"Synapse"},{"key":"3207_CR65","unstructured":"Seeman P (2024) Yes, breast is best, but taper domperidone when stopping"},{"key":"3207_CR66","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.tips.2011.05.002","volume":"32","author":"SK Shenoy","year":"2011","unstructured":"Shenoy SK, Lefkowitz RJ (2011) \u03b2-arrestin-mediated receptor trafficking and signal transduction. Trends Pharmacol Sci 32:521\u2013533. https:\/\/doi.org\/10.1016\/j.tips.2011.05.002","journal-title":"Trends Pharmacol Sci"},{"key":"3207_CR67","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1007\/s002130000532","volume":"152","author":"S Silvestri","year":"2000","unstructured":"Silvestri S, Seeman MV, Negrete J-C et al (2000) Increased dopamine D 2 receptor binding after long-term treatment with antipsychotics in humans: a clinical PET study. Psychopharmacology 152:174\u2013180. https:\/\/doi.org\/10.1007\/s002130000532","journal-title":"Psychopharmacology"},{"key":"3207_CR68","first-page":"319","volume":"51","author":"H Singh","year":"1990","unstructured":"Singh H, Hunt JI, Vitiello B, Simpson GM (1990) Neuroleptic withdrawal in patients meeting criteria for supersensitivity psychosis. J Clin Psychiatry 51:319\u2013321","journal-title":"J Clin Psychiatry"},{"key":"3207_CR69","first-page":"285","volume":"1","author":"RC Smith","year":"1975","unstructured":"Smith RC, Davis JM (1975) Behavioral supersensitivity to apomorphine and amphetamine after chronic high dose haloperidol treatment. Psychopharmacol Commun 1:285\u2013293","journal-title":"Psychopharmacol Commun"},{"key":"3207_CR70","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1111\/j.1600-0447.1990.tb05477.x","volume":"81","author":"W Steiner","year":"1990","unstructured":"Steiner W, Laporta M, Chouinard G (1990) Neuroleptic-induced supersensitivity psychosis in patients with bipolar affective disorder. Acta Psychiatr Scand 81:437\u2013440. https:\/\/doi.org\/10.1111\/j.1600-0447.1990.tb05477.x","journal-title":"Acta Psychiatr Scand"},{"key":"3207_CR71","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.psychres.2015.02.021","volume":"227","author":"T Suzuki","year":"2015","unstructured":"Suzuki T, Kanahara N, Yamanaka H et al (2015) Dopamine supersensitivity psychosis as a pivotal factor in treatment-resistant schizophrenia. Psychiatry Res 227:278\u2013282. https:\/\/doi.org\/10.1016\/j.psychres.2015.02.021","journal-title":"Psychiatry Res"},{"key":"3207_CR72","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1097\/FBP.0000000000000563","volume":"31","author":"AM Szota","year":"2020","unstructured":"Szota AM, Scheel-Kr\u00fcger J (2020) The role of glutamate receptors and their interactions with dopamine and other neurotransmitters in the development of tardive dyskinesia: preclinical and clinical results. Behav Pharmacol 31:511\u2013523. https:\/\/doi.org\/10.1097\/FBP.0000000000000563","journal-title":"Behav Pharmacol"},{"key":"3207_CR73","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.ajp.2016.08.014","volume":"24","author":"M Tachibana","year":"2016","unstructured":"Tachibana M, Niitsu T, Watanabe M et al (2016) Effectiveness of blonanserin for patients with drug treatment-resistant schizophrenia and dopamine supersensitivity: A retrospective analysis. Asian J Psychiatry 24:28\u201332. https:\/\/doi.org\/10.1016\/j.ajp.2016.08.014","journal-title":"Asian J Psychiatry"},{"key":"3207_CR74","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1177\/0269881115570083","volume":"29","author":"M Takase","year":"2015","unstructured":"Takase M, Kanahara N, Oda Y et al (2015) Dopamine supersensitivity psychosis and dopamine partial agonist: a retrospective survey of failure of switching to aripiprazole in schizophrenia. J Psychopharmacol Oxf Engl 29:383\u2013389. https:\/\/doi.org\/10.1177\/0269881115570083","journal-title":"J Psychopharmacol Oxf Engl"},{"key":"3207_CR75","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.schres.2017.03.014","volume":"190","author":"M Takase","year":"2017","unstructured":"Takase M, Kanahara N, Oda Y et al (2017) The impacts of dopamine D2 receptor polymorphism and antipsychotic dosage on dopamine supersensitivity psychosis in schizophrenia. Schizophr Res 190:182\u2013183. https:\/\/doi.org\/10.1016\/j.schres.2017.03.014","journal-title":"Schizophr Res"},{"key":"3207_CR76","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1177\/0269881119900982","volume":"34","author":"M Takase","year":"2020","unstructured":"Takase M, Kimura H, Kanahara N et al (2020) Plasma monoamines change under dopamine supersensitivity psychosis in patients with schizophrenia: A comparison with first-episode psychosis. J Psychopharmacol Oxf Engl 34:540\u2013547. https:\/\/doi.org\/10.1177\/0269881119900982","journal-title":"J Psychopharmacol Oxf Engl"},{"key":"3207_CR77","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1097\/JCP.0b013e3181accfec","volume":"29","author":"H Takeuchi","year":"2009","unstructured":"Takeuchi H, Uchida H, Suzuki T et al (2009) Predictors of Clinical Worsening After a Switch to Aripiprazole in Patients With Schizophrenia: A 1-Year Naturalistic Follow-Up Study. J Clin Psychopharmacol 29:394\u2013395. https:\/\/doi.org\/10.1097\/JCP.0b013e3181accfec","journal-title":"J Clin Psychopharmacol"},{"key":"3207_CR78","first-page":"431","volume":"12","author":"D Tarsy","year":"1977","unstructured":"Tarsy D, Baldessarini RJ (1977) The pathophysiologic basis of tardive dyskinesia. Biol Psychiatry 12:431\u2013450","journal-title":"Biol Psychiatry"},{"key":"3207_CR79","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1097\/YCO.0000000000000598","volume":"33","author":"IA Thompson","year":"2020","unstructured":"Thompson IA, De Vries EFJ, Sommer IEC (2020) Dopamine D2 up-regulation in psychosis patients after antipsychotic drug treatment. Curr Opin Psychiatry 33:200\u2013205. https:\/\/doi.org\/10.1097\/YCO.0000000000000598","journal-title":"Curr Opin Psychiatry"},{"key":"3207_CR80","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1176\/appi.ajp.20240321","volume":"182","author":"J Tiihonen","year":"2025","unstructured":"Tiihonen J, Tanskanen A, Solmi M et al (2025) Continuous Dopamine D2 Receptor Blockade and Long-Term Outcome in First-Episode Schizophrenia. Am J Psychiatry 182:341\u2013348. https:\/\/doi.org\/10.1176\/appi.ajp.20240321","journal-title":"Am J Psychiatry"},{"key":"3207_CR81","doi-asserted-by":"publisher","first-page":"2433936","DOI":"10.1080\/14796708.2024.2433936","volume":"19","author":"K Uludag","year":"2024","unstructured":"Uludag K (2024) Brain imaging studies on Tardive Dyskinesia in schizophrenia patients and animal models: a comprehensive review. Future Neurol 19:2433936. https:\/\/doi.org\/10.1080\/14796708.2024.2433936","journal-title":"Future Neurol"},{"key":"3207_CR82","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1016\/j.bpsc.2025.07.004","volume":"10","author":"I Varvari","year":"2025","unstructured":"Varvari I, Bolte L, Colli C et al (2025) Glutamatergic Modulation of Brain Function in Psychosis: A Systematic Review of Neuroimaging Studies. Biol Psychiatry Cogn Neurosci Neuroimaging 10:1221\u20131238. https:\/\/doi.org\/10.1016\/j.bpsc.2025.07.004","journal-title":"Biol Psychiatry Cogn Neurosci Neuroimaging"},{"key":"3207_CR83","doi-asserted-by":"crossref","unstructured":"Velligan DI, Weiden PJ, Sajatovic M, et al (2009) The expert consensus guideline series: adherence problems in patients with serious and persistent mental illness. J Clin Psychiatry 70 Suppl 4:1\u201346; quiz 47\u201348","DOI":"10.4088\/JCP.7090su1cj"},{"key":"3207_CR84","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1097\/00004714-198105000-00002","volume":"1","author":"DR Weinberger","year":"1981","unstructured":"Weinberger DR, Bigelow LB, Klein ST, Jed Wyatt R (1981) Drug Withdrawal in Chronic Schizophrenic Patients: in Search of Neuroleptic-Induced Supersensitivity Psychosis. J Clin Psychopharmacol 1:120\u2013123. https:\/\/doi.org\/10.1097\/00004714-198105000-00002","journal-title":"J Clin Psychopharmacol"},{"key":"3207_CR85","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.schres.2016.01.013","volume":"170","author":"H Yamanaka","year":"2016","unstructured":"Yamanaka H, Kanahara N, Suzuki T et al (2016) Impact of dopamine supersensitivity psychosis in treatment-resistant schizophrenia: An analysis of multi-factors predicting long-term prognosis. Schizophr Res 170:252\u2013258. https:\/\/doi.org\/10.1016\/j.schres.2016.01.013","journal-title":"Schizophr Res"},{"key":"3207_CR86","doi-asserted-by":"publisher","first-page":"174","DOI":"10.2174\/1570159X14666160606093602","volume":"15","author":"J Yin","year":"2017","unstructured":"Yin J, Barr AM, Ramos-Miguel A, Procyshyn RM (2017) Antipsychotic Induced Dopamine Supersensitivity Psychosis: A Comprehensive Review. Curr Neuropharmacol 15:174\u2013183. https:\/\/doi.org\/10.2174\/1570159X14666160606093602","journal-title":"Curr Neuropharmacol"},{"key":"3207_CR87","doi-asserted-by":"publisher","first-page":"6773","DOI":"10.1038\/s41598-026-37396-z","volume":"16","author":"T Yu","year":"2026","unstructured":"Yu T, Li Y, Li N et al (2026) Decreased N-acetylaspartate plus N-acetyl-aspartyl-glutamate levels in the caudate of schizophrenia patients with tardive dyskinesia. Sci Rep 16:6773. https:\/\/doi.org\/10.1038\/s41598-026-37396-z","journal-title":"Sci Rep"},{"key":"3207_CR88","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajp.2024.104317","volume":"103","author":"S Zemach","year":"2025","unstructured":"Zemach S, Zohar J (2025) The importance of proper naming \u2013 A review of Neuroscience-based Nomenclature (NbN). Asian J Psychiatry 103:104317. https:\/\/doi.org\/10.1016\/j.ajp.2024.104317","journal-title":"Asian J Psychiatry"},{"key":"3207_CR89","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.baga.2011.11.004","volume":"2","author":"H Zhang","year":"2012","unstructured":"Zhang H, Sulzer D (2012) Regulation of striatal dopamine release by presynaptic auto- and heteroreceptors. Basal Ganglia 2:5\u201313. https:\/\/doi.org\/10.1016\/j.baga.2011.11.004","journal-title":"Basal Ganglia"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-026-03207-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00702-026-03207-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-026-03207-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T10:19:20Z","timestamp":1792577960000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00702-026-03207-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,3]]},"references-count":89,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["3207"],"URL":"https:\/\/doi.org\/10.1007\/s00702-026-03207-y","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,3]]},"assertion":[{"value":"24 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflicts of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}